AHA today urged the U.S. District Court for the District of Columbia to order the Department of Health and Human Services to promptly repay 340B hospitals for unlawful payment cuts in previous years, given the agency’s continued delay in implementing or even proposing a remedy on its own. 
 
After AHA’s unanimous victory in the U.S. Supreme Court this summer, the D.C. court ordered HHS to halt its unlawful 340B cuts for the remainder of 2022. In a final rule released this week for CY 2023, the agency said it would defer any proposal of a remedy for CYs 2018-2021 until sometime before next year’s CY 2024 payment rule. 
 
“Despite having already sought comment twice, HHS has again deferred announcing any specific remedy proposal and indicated that it will solicit a third round of comments,” AHA told the court today. “But no further public comments are needed for the agency to remediate years of illegal underpayments and for Defendants to promptly pay 340B hospitals the difference between ASP plus 6% and what they were previously paid, without seeking retroactive claw backs in the name of budget neutrality. In fact, following this Court’s September 28 Order with respect to the remainder of 2022, Defendants quickly announced that they would cease their illegal conduct and be able to ‘reprocess claims our contractors paid on or after September 28, 2022.’ By swiftly acceding to the Court’s order, HHS fatally undermined its arguments that such an order would be administratively difficult or unconstitutional.”
 

Related News Articles

Headline
The AHA today released a new report showing how the unlawful actions of drug companies to limit 340B pricing with community and specialty pharmacies are…
Headline
The Centers for Medicare & Medicaid Services late today posted a final rule on its website that will increase Medicare hospital outpatient prospective…
Headline
As a result of AHA’s successful litigation to stop the Centers for Medicare & Medicaid Services’ unlawful 340B payment policy in calendar year 2022,…
Headline
“For three decades, the 340B drug pricing program has helped hospitals that serve high numbers of low-income patients offer and expand a range of important…
Headline
The Department of Health and Human Services will begin restoring a payment rate of average sales price plus 6% for 340B drug claims in about two weeks, the…
Headline
The United States District Court for the District of Columbia today ruled in favor of the AHA, holding that the Department of Health and Human Services…